You have been successfully logged out.
The content of this webpage is promotional, and may contain information about Gilead's medicinal products. It is intended only for healthcare professionals and other relevant decision makers in the UK.
Recorded: November 17th 2022
Duration: 33:26
Dr Ahmed Elsharkawy talked about re-testing as a key part of hepatitis C elimination strategy. He highlighted the great progress in some settings such as prisons, and the remaining opportunities in other key populations. Reinfection in current injectors, for example, remains a key challenge that may be addressed by embedding re-testing in service providers’ standard operating procedures.
Ahmed Elsharkawy was a consultant hepatologist in Birmingham. He had a major interest in viral hepatitis and pioneered hepatitis C outreach clinics for marginalised populations in the city. He was a past Chairman of the British Viral hepatitis Group and led the BASL specialist interest group in hepatitis B. He was a strong advocate for the patient voice in viral hepatitis elimination and had been involved in trying to set up the first UK hepatitis B patient group.
Prescribing information
HCV Medicines Prescribing Information
LIVER Connect Meetings
As requested by attendees, a selection of webinars from
2022 onwards are now available to
watch on demand
You can also register here to attend the live webinars
UKI-UNB-2444 | June 2026